\begin{table*}[!t]
  \caption{Overall performance comparison across methods, averaged over targets. For $r_1$, $r_2$, $r_3$, $r_4$, $r_5$ and $\tilde{r}$, the value represents the percentage ($\%$) and the number ($\#$) of compounds that satisfy the objectives. For $r_6$, $r_7$, and their combinations (including $\tilde{r}$), the values represent the percentage of the sets of compounds that satisfy the objectives. Success Rate denotes the percentage of targets where the method can successfully generate novel and diverse potential drug candidates. \textbf{Bold} and \underline{underline} indicate top and second-best performance, respectively.}
  \label{tab:main}
  \centering
  \footnotesize
  \begin{threeparttable}
      \begin{tabular}{
        @{\hspace{8pt}}l@{\hspace{2pt}}
        %
        @{\hspace{8pt}}l@{\hspace{2pt}}
                %
        @{\hspace{4pt}}r@{\hspace{2pt}}r@{\hspace{4pt}}
        @{\hspace{4pt}}r@{\hspace{2pt}}r@{\hspace{4pt}}
        @{\hspace{4pt}}r@{\hspace{2pt}}r@{\hspace{4pt}}
        @{\hspace{4pt}}r@{\hspace{2pt}}r@{\hspace{4pt}}
        @{\hspace{4pt}}r@{\hspace{2pt}}r@{\hspace{4pt}}
        @{\hspace{4pt}}r@{\hspace{2pt}}r@{\hspace{4pt}}
        @{\hspace{4pt}}r@{\hspace{2pt}}r@{\hspace{8pt}}
      }
      \toprule
      && \multicolumn{2}{c}{Pocket2Mol} & \multicolumn{2}{c}{DiffSMOL} & \multicolumn{2}{c}{Claude} & \multicolumn{2}{c}{GPT4o} & \multicolumn{2}{c}{o1-mini} & \multicolumn{2}{c}{o1} & \multicolumn{2}{c}{Ours} \\
      \cmidrule(){3-4} \cmidrule(){5-6} \cmidrule(){7-8} \cmidrule(){9-10} \cmidrule(){11-12} \cmidrule(){13-14} \cmidrule(){15-16}
      && $\%$ & $\#$ & $\%$ & $\#$ & $\%$ & $\#$ & $\%$ & $\#$ & $\%$ & $\#$ & $\%$ & $\#$ & $\%$ & $\#$ \\
      \midrule
           \multirow{15}{*}{\rotatebox{90}{molecules during the workflow}}
      & average $\#$generated molecules across targets
      &  & $100.0$ 
      &  & $100.0$ & $100.0$ & $\phantom{0}\phantom{0}5.0$ & $100.0$ & $\phantom{0}\phantom{0}5.0$ & $100.0$ & $\phantom{0}\phantom{0}5.0$ & $100.0$ & $\phantom{0}\phantom{0}5.0$ & $100.0$ & $\phantom{0}24.5$ \\
      %
      %& $\#$ Valid 
      & valid generated molecules
      & $100.0$ & $100.0$ & $99.9$ & $99.9$ & $98.7$ & $4.9$ & $97.3$ & $4.9$ & $91.3$ & $4.6$ & $95.3$ & $4.8$ & $100.0$ & $24.5$ \\
      %
      %\midrule
      \cmidrule(){2-16}
      %$r_1$ ($\mathcal{N}$) 
      & $\noveltyreq\ge0.8$
      & $87.6$ & $87.6$ & $\mathbf{98.2}$ & $98.2$ & $46.9$ & $2.4$ & $68.3$ & $3.4$ & $64.1$ & $3.2$ & $55.9$ & $2.8$ & $\underline{97.8}$ & $22.4$ \\
      %$r_2$ (QED) 
      & \qedreq (only to QED)
      & $53.4$ & $53.4$ & $60.0$ & $60.0$ & $\underline{96.7}$ & $4.8$ & $88.2$ & $4.4$ & $90.1$ & $4.5$ & $88.3$ & $4.4$ & $\mathbf{97.2}$ & $21.8$ \\
      %$r_3$ (Lipinski) 
      &\lipinskireq
      & $\mathbf{99.7}$ & $99.7$ & $72.1$ & $72.1$ & $\underline{98.7}$ & $4.9$ & $95.9$ & $4.8$ & $90.7$ & $4.5$ & $95.3$ & $4.8$ & $96.7$ & $21.8$ \\
      %$r_4$ (SAScore) 
      &\sascorereq
      & $77.4$ & $77.4$ & $7.5$ & $7.5$ & $\mathbf{92.7}$ & $4.6$ & $90.7$ & $4.5$ & $81.4$ & $4.1$ & $\underline{92.6}$ & $4.6$ & $88.3$ & $17.4$ \\
      %$r_5$ (Vina) 
      & \vinareq
      & $15.3$ & $15.3$ & $24.7$ & $24.7$ & $\underline{63.3}$ & $3.2$ & $59.2$ & $3.0$ & $47.9$ & $2.3$ & $34.6$ & $1.8$ & $\mathbf{95.8}$ & $21.2$ \\
      %$\tilde{r}:r_1r_2r_3r_4r_5$ 
      & All above (\xia{drug candidates})
      & $6.4$ & $6.4$ & $0.7$ & $0.7$ & $30.3$ & $1.5$ & $\underline{35.0}$ & $1.7$ & $28.2$ & $1.4$ & $20.7$ & $1.0$ & $\mathbf{84.0}$ & $14.5$ \\
      \cmidrule(){2-16}
      %\midrule
      %& \hl{$r_6$ ($\#$)}
      & can generate 5
      & $\mathbf{100.0}$ & $30$ & $\mathbf{100.0}$ & $30$ & $\underline{93.3}$ & $28$ & $87.7$ & $26$ & $73.3$ & $22$ & $80.0$ & $24$ & $90.0$ & $27$ \\
%      & \hl{$r_7$ (Diversity)} 
	& $\diversityreq\ge0.8$
      & $\mathbf{100.0}$ & $30$ & $\mathbf{100.0}$ & $30$ & $30.0$ & $9$ & $90.0$ & $27$ & $67.7$ & $20$ & $70.0$ & $21$ & $\underline{97.7}$ & $29$ \\
      %& \hl{$r_6r_7$} 
      & \targetn
      & $\mathbf{100.0}$ & $30$ & $\mathbf{100.0}$ & $30$ & $27.7$ & $8$ & $77.7$ & $23$ & $43.3$ & $13$ & $57.7$ & $17$ & $\underline{90.0}$ & $27$ \\
      %& \hl{$\tilde{r}r_6$} 
      & at least 5 drug candidates
      & $\underline{27.7}$ & $8$ & $3.3$ & $1$ & $23.3$ & $7$ & $10.0$ & $3$ & $0.0$ & $0$ & $3.3$ & $1$ & $\mathbf{73.3}$ & $22$  \\
      %& \hl{$\tilde{r}r_7$} 
      & drug candidates and diverse
      & $23.3$ & 7 & $10.0$ & 3 & $10.0$ & 3 & $\underline{33.3}$ & $10$ & $\underline{33.3}$ & $10$ & $20.0$ & 6 & $\mathbf{90}$ & $27$ \\
      %\midrule
      \cmidrule(){2-16}
      & \successrate & $\underline{23.3}$ & 7 & $0.0$ & 0 & $6.7$ & 2 & $6.7$ & 2 & $0.0$ & 0 & $0.0$ & 0 & $\mathbf{73.3}$ & 22 \\
      \midrule
      % Novelty$\uparrow$ & \multicolumn{2}{r}{$\underline{0.87 \pm 0.05}$} & \multicolumn{2}{r}{$\mathbf{0.89 \pm 0.02}$} & \multicolumn{2}{r}{$0.77 \pm 0.12$} & \multicolumn{2}{r}{$0.82 \pm 0.07$} & \multicolumn{2}{r}{$0.79 \pm 0.15$} & \multicolumn{2}{r}{$0.80 \pm 0.10$} & \multicolumn{2}{r}{$0.86 \pm 0.04$} \\
      % QED$\uparrow$ & \multicolumn{2}{r}{$0.51 \pm 0.06$} & \multicolumn{2}{r}{$0.55 \pm 0.17$} & \multicolumn{2}{r}{$\mathbf{0.78 \pm 0.10}$} & \multicolumn{2}{r}{$0.74 \pm 0.08$} & \multicolumn{2}{r}{$0.75 \pm 0.16$} & \multicolumn{2}{r}{$\underline{0.77 \pm 0.06}$} & \multicolumn{2}{r}{$0.69 \pm 0.11$} \\
      % Lipinski$\uparrow$ & \multicolumn{2}{r}{$\mathbf{4.00 \pm 0.01}$} & \multicolumn{2}{r}{$3.43 \pm 0.88$} & \multicolumn{2}{r}{$\mathbf{4.00 \pm 0.00}$} & \multicolumn{2}{r}{$\underline{3.99 \pm 0.06}$} & \multicolumn{2}{r}{$3.85 \pm 0.72$} & \multicolumn{2}{r}{$\mathbf{4.00 \pm 0.00}$} & \multicolumn{2}{r}{$3.93 \pm 0.16$} \\
      % SAScore$\downarrow$ & \multicolumn{2}{r}{$2.46 \pm 0.36$} & \multicolumn{2}{r}{$6.15 \pm 1.59$} & \multicolumn{2}{r}{$2.30 \pm 0.52$} & \multicolumn{2}{r}{$2.16 \pm 0.31$} & \multicolumn{2}{r}{$\mathbf{2.02 \pm 0.48}$} & \multicolumn{2}{r}{$\underline{2.03 \pm 0.31}$} & \multicolumn{2}{r}{$2.62 \pm 0.51$} \\
      % Vina$\downarrow$ & \multicolumn{2}{r}{$-4.74 \pm 0.88$} & \multicolumn{2}{r}{$-4.23 \pm 1.84$} & \multicolumn{2}{r}{$\underline{-6.69 \pm 1.10}$} & \multicolumn{2}{r}{$-6.56 \pm 1.15$} & \multicolumn{2}{r}{$-6.31 \pm 1.51$} & \multicolumn{2}{r}{$-5.97 \pm 0.87$} & \multicolumn{2}{r}{$\mathbf{-7.17 \pm 1.08}$} \\
      % Diversity$\uparrow$ & \multicolumn{2}{r}{$\underline{0.88 \pm 0.02}$} & \multicolumn{2}{r}{$\mathbf{0.89 \pm 0.01}$} & \multicolumn{2}{r}{$0.76 \pm 0.08$} & \multicolumn{2}{r}{$0.84 \pm 0.04$} & \multicolumn{2}{r}{$0.79 \pm 0.15$} & \multicolumn{2}{r}{$0.80 \pm 0.09$} & \multicolumn{2}{r}{$0.82 \pm 0.10$} \\      
      %
      \multirow{6}{*}{\rotatebox{90}{\centering{average metric of molecules generated by the method across targets}}}
      & \noveltyreq$\uparrow$ & \multicolumn{2}{r}{$\underline{0.87}$} & \multicolumn{2}{r}{$\mathbf{0.89}$} & \multicolumn{2}{r}{$0.77$} & \multicolumn{2}{r}{$0.82$} & \multicolumn{2}{r}{$0.79$} & \multicolumn{2}{r}{$0.80$} & \multicolumn{2}{r}{$0.86$} \\
     &  \qedreq$\uparrow$ & \multicolumn{2}{r}{$0.51$} & \multicolumn{2}{r}{$0.55$} & \multicolumn{2}{r}{$\mathbf{0.78}$} & \multicolumn{2}{r}{$0.74$} & \multicolumn{2}{r}{$0.75$} & \multicolumn{2}{r}{$\underline{0.77}$} & \multicolumn{2}{r}{$0.69$} \\
      & \lipinskireq$\uparrow$ & \multicolumn{2}{r}{$\mathbf{4.00}$} & \multicolumn{2}{r}{$3.43$} & \multicolumn{2}{r}{$\mathbf{4.00}$} & \multicolumn{2}{r}{$
      \underline{3.99}$} & \multicolumn{2}{r}{$3.85$} & \multicolumn{2}{r}{$\mathbf{4.00}$} & \multicolumn{2}{r}{$3.93$} \\
      & \sascorereq$\downarrow$ & \multicolumn{2}{r}{$2.46$} & \multicolumn{2}{r}{$6.15$} & \multicolumn{2}{r}{$2.30$} & \multicolumn{2}{r}{$2.16$} & \multicolumn{2}{r}{$\mathbf{2.02}$} & \multicolumn{2}{r}{$\underline{2.03}$} & \multicolumn{2}{r}{$2.62$} \\
      & \vinareq$\downarrow$ & \multicolumn{2}{r}{$-4.74$} & \multicolumn{2}{r}{$-4.23$} & \multicolumn{2}{r}{$\underline{-6.69}$} & \multicolumn{2}{r}{$-6.56$} & \multicolumn{2}{r}{$-6.31$} & \multicolumn{2}{r}{$-5.97$} & \multicolumn{2}{r}{$\mathbf{-7.17}$} \\
      & \diversityreq$\uparrow$ & \multicolumn{2}{r}{$\underline{0.88}$} & \multicolumn{2}{r}{$\mathbf{0.89}$} & \multicolumn{2}{r}{$0.76$} & \multicolumn{2}{r}{$0.84$} & \multicolumn{2}{r}{$0.79$} & \multicolumn{2}{r}{$0.80$} & \multicolumn{2}{r}{$0.82$} \\
      \bottomrule
      \end{tabular}
  \end{threeparttable}
  % \vskip -15pt
\end{table*}